Literature DB >> 20859488

Interpretation of arterial blood gas.

Pramod Sood1, Gunchan Paul, Sandeep Puri.   

Abstract

Disorders of acid-base balance can lead to severe complications in many disease states, and occasionally the abnormality may be so severe as to become a life-threatening risk factor. The process of analysis and monitoring of arterial blood gas (ABG) is an essential part of diagnosing and managing the oxygenation status and acid-base balance of the high-risk patients, as well as in the care of critically ill patients in the Intensive Care Unit. Since both areas manifest sudden and life-threatening changes in all the systems concerned, a thorough understanding of acid-base balance is mandatory for any physician, and the anesthesiologist is no exception. However, the understanding of ABGs and their interpretation can sometimes be very confusing and also an arduous task. Many methods do exist in literature to guide the interpretation of the ABGs. The discussion in this article does not include all those methods, such as analysis of base excess or Stewart's strong ion difference, but a logical and systematic approach is presented to enable us to make a much easier interpretation through them. The proper application of the concepts of acid-base balance will help the healthcare provider not only to follow the progress of a patient, but also to evaluate the effectiveness of care being provided.

Entities:  

Keywords:  ABG analysis; Anion gap; Approach to mixed disorders; Arterial blood gas interpretation; rules for rapid ABG analysis

Year:  2010        PMID: 20859488      PMCID: PMC2936733          DOI: 10.4103/0972-5229.68215

Source DB:  PubMed          Journal:  Indian J Crit Care Med        ISSN: 0972-5229


Introduction

Arterial blood gas (ABG) analysis is an essential part of diagnosing and managing a patient’s oxygenation status and acid–base balance. The usefulness of this diagnostic tool is dependent on being able to correctly interpret the results. Disorders of acid–base balance can create complications in many disease states, and occasionally the abnormality may be so severe so as to become a life-threatening risk factor. A thorough understanding of acid–base balance is mandatory for any physician, and intensivist, and the anesthesiologist is no exception. The three widely used approaches to acid–base physiology are the HCO3- (in the context of pCO2), standard base excess (SBE), and strong ion difference (SID). It has been more than 20 years since the Stewart’s concept of SID was introduced, which is defined as the absolute difference between completely dissociated anions and cations. According to the principle of electrical neutrality, this difference is balanced by the weak acids and CO2. The SID is defined in terms of weak acids and CO2 subsequently has been re-designated as effective SID (SIDe) which is identical to “buffer base.” Similarly, Stewart’s original term for total weak acid concentration (ATOT) is now defined as the dissociated (A-) plus undissociated (AH) weak acid forms. This is familiarly known as anion gap (AG), when normal concentration is actually caused by A-. Thus all the three methods yield virtually identical results when they are used to quantify acid–base status of a given blood sample.[1]

Why is it Necessary to Order an ABG Analysis?

The utilization of an ABG analysis becomes necessary in view of the following advantages: Aids in establishing diagnosis. Guides treatment plan. Aids in ventilator management. Improvement in acid/base management; allows for optimal function of medications. Acid/base status may alter electrolyte levels critical to a patient’s status. Accurate results for an ABG depend on the proper manner of collecting, handling, and analyzing the specimen. Clinically important errors may occur at any of the above steps, but ABG measurements are particularly vulnerable to preanalytic errors. The most common problems that are encountered include nonarterial samples, air bubbles in the sample, inadequate or excessive anticoagulant in the sample, and delayed analysis of a noncooled sample.

Potential Preanalytical Errors

Preanalytical errors are caused at the following stages:

During preparation prior to sampling

Missing or wrong patient/sample identification; Use of the incorrect type or amount of anticoagulant - dilution due to use of liquid heparin; - insufficient amount of heparin; - binding of electrolytes to heparin; Inadequate stabilization of the respiratory condition of the patient; and Inadequate removal of flush solution in arterial lines prior to blood collection.

During sampling/handling

Mixture of venous and arterial blood during puncturing; Air bubbles in the sample. Any air bubble in the sample must be expelled as soon as possible after withdrawing the sample and before mixing with heparin or before any cooling of the sample has been done. An air bubble whose relative volume is up to 1% of the blood in the syringe is a potential source of significant error and may seriusly affect the pO2 value. Insufficient mixing with heparin.

During storage/transport

Incorrect storage Hemolysis of blood cells

General Storage Recommendation

Do not cool the sample.[2] Analyze within 30 min. For samples with high paO2 e.g., shunt or with high leukocyte or platelet count also analyze within 5 min. When analysis is expected to be delayed for more than 30 minutes, use of glass syringes and ice slurry is recommended.

During preparation prior to sample transfer

Visually inspect the sample for clots. Inadequate mixing of sample before analysis. Insufficient mixing can cause coagulation of the sample. It is recommended to mix the blood sample thoroughly by inverting the syringe 10 times and rolling it between the palms as shown in Figure 1. This prevents stacking (such as coins or plates) of red blood cells.
Figure 1

Correct method of mixing of the arterial sample with the anticoagulant in two dimensions to prevent stacking of red blood cells.

Correct method of mixing of the arterial sample with the anticoagulant in two dimensions to prevent stacking of red blood cells.

During anticoagulation

Modern blood gas syringes and capillary tubes are coated with various types of heparin to prevent coagulation in the sampler and inside the blood gas analyzer: Liquid nonbalanced heparin Dry nonbalanced heparin Dry electrolyte-balanced heparin (Na+, K+, Ca2+) Dry Ca2+-balanced heparin Other anticoagulants, e.g., citrate and EDTA are both slightly acidic which increase the risk of pH being falsely lowered.

Liquid heparin

The use of liquid heparin as the anticoagulant causes a dilution of the sample, i.e., dilutes the plasma, but not the contents of the blood cells. As a consequence, parameters such as pCO2 and electrolytes are affected. Only 0.05 mL of heparin is required to anticoagulate 1 mL of blood. Dead space volume of a standard 5 mL syringe with 1 inch 22 gauge needle is 0.2 mL; filling the syringe dead space with heparin provides sufficient volume to anticoagulate a 4-mL blood sample. If smaller sample volumes are obtained or more liquid heparin is left in the syringe, then the dilution effect will be even greater. The dilution effect also depends on the hematocrit value. Plasma electrolytes decrease linearly with the dilution of the plasma along with pCO2, cGlucose, and ctHb values. pH and pO2 values are relatively unaffected by dilution. paO2 is only as little as 2% of the O2 physically dissolved in the plasma, and so the oximetry parameters given in fractions (or %) will remain unaffected.[3] Syringes for blood gas analysis can have a wide range of heparin amounts.[4] The units are typically given as IU/mL (international units of heparin per milliliter) blood drawn into the syringe. In order to obtain a sufficient final concentration of heparin in the sample, blood volume recommended on the syringe must be drawn. Example: a syringe stated to contain 50 IU/mL when filled with 1.5 mL of blood means that the syringe contains a total 75 IU of dry heparin. If the user draws 2 mL of blood, then the resulting heparin concentration will be too low and the sample may coagulate. If the user draws only 1 mL, then the resulting heparin concentration will be higher than that aimed for, which may lead to producing falsely low electrolyte results. Heparin binds to positive ions such as Ca2+, K+, and Na+. Electrolytes bound to heparin cannot be measured by ion-selective electrodes, and the final effect will be measurement offalsely low values. The binding effect and the resulting inaccuracy of results are especially significant for corrected Ca2+. The use of electrolyte-balanced heparin significantly reduces the binding effect and the resulting inaccuracy.[5] The following steps for rapid interpretation of ABG are recommended:

Check for the consistency of ABG

While making an interpretation of an ABG always check for the consistency of the report by the modified Henderson equation. The hydrogen ion is calculated by subtracting the two digits after the decimal point of pH from 80, e.g., if the pH is 7.23 then [H+] = 80 - 23 = 57 or [H+] = 10(9-pH) The hydrogen can be calculated from Table 1.
Table 1

pH value and corresponding H+ ion concentration

pHH+pHH+
6.702007.4040
6.751787.4535
6.801587.5032
6.851417.5528
6.901267.6025
6.951127.6522
7.001007.7020
7.05897.7518
7.10797.8016
7.15717.8514
7.20637.9013
7.25567.9511
7.30508.0010
7.3545
pH value and corresponding H+ ion concentration

Obtain a relevant clinical history

While making an interpretation of anABG, never comment on the ABG without obtaining a relevant clinical history of the patient, which gives a clue to the etiology of the given acid–base disorder. For example, a patient with a history of hypotension, renal failure, uncontrolled diabetic status, of treatment with drugs such as metformin is likely to have metabolic acidosis; a patient, with a history of diuretic use, bicarbonate administration, high-nasogastric aspirate, and vomiting, is likely to have metabolic alkalosis. Respiratory acidosis would occur in COPD, muscular weakness, postoperative cases, and opioid overdose, and respiratory alkalosis is likely to occur in sepsis, hepatic coma, and pregnancy.

Look at the oxygenation status of the patient

The oxygenation status of the patient is judged by the paO2;however, never comment on the oxygenation status without knowing the corresponding FiO2. Calculate the expected paO2 (generally five times the FiO2).[6] Based on the expected paO2 classify as mild, moderate, and severe hypoxia.

Ventilatory status

Look at paCO2.

Acid–base status

Identify the primary disorder by looking at the pH pH > 7.40–Alkalemia: – 7.40-Acidemia Then look at paCO2 which is a respiratory acid, whether it is increased, i.e., >40 (acidosis) or decreased <40 (alkalosis) and if this explains the change of pH, then it is respiratory disorder; otherwise, see the trend of change of HCO3-(whether increased in alkalosis or decreased in acidosis)–if it explains the change of pH, then it is a metabolic disorder.

In a normal ABG

pH and paCO2 move in opposite directions. HCO3-and paCO2 move in same direction. When the pH and paCO2 change in the same direction (which normally should not), the primary problem is metabolic; when pH and paCO2 move in opposite directions and paCO2 is normal, then the primary problem is respiratory. Mixed Disorder–if HCO3- and paCO2 change in opposite direction (which they normally should not), then it is a mixed disorder: pH may be normal with abnormal paCO2 or abnormal pH and normal paCO2).[7] If the trend of change in paCO2 and HCO3- is the same, check the percent difference. The one, with greater % difference, between the two is the one that is the dominant disorder. e.g.: pH = 7.25 HCO3-=16 paCO2=60 Here, the pH is acidotic and both paCO2 and HCO3- explain its acidosis: so look at the % difference HCO3-% difference = (24 - 16)/24 = 0.33 paCO2% difference = (60 - 40)/40 = 0.5 Therefore, respiratory acidosis as the dominant disorder.

Respiratory disorders

After the primary disorder is established as respiratory, then the following points will help us to approach further with regard to the respiratory disorder).[8] Ratio of rate of change in H+to change in paCO2 Alveolar arterial oxygen gradient Compensation

Ratio of rate of change in H+to change in paCO2

The above ratio of rate of change in H+to change in paCO2 helps in guiding us to conclude whether the respiratory disorder is acute, chronic, or acute on chronic. As we have seen, the hydrogen can be calculated from Table 1 and the change in H+ is calculated by subtracting the normal H+ from the calculated H+ ion.[9] >0.8–acute 0.3–0.8–acute on chronic

Alveolar Arterial Oxygen Gradient

It is calculated as follows: where PAO2, alveolar partial pressure of oxygen; PiO2, partial pressure of inspired oxygen; FiO2, fraction of inspired oxygen; PB, barometric pressure (760 mmHg at sea level); PH2O, water vapor pressure (47 mm Hg), PaCO2, partial pressure of carbon dioxide in blood; R, respiratory quotient assumed to be 0.8. Hypoxemic respiratory failure can be associated with normal (10–15 mmHg) or increasedalveolar arterial oxygen gradient. Figure 2 shows the alogrithim for approach in a patient with hypoxemic respiratory failure. If this gradient is <20, then it indicates an extrapulmonary cause of respiratory failure.
Figure 2

Flow diagram showing approach to hypoxemic respiratory failure

Flow diagram showing approach to hypoxemic respiratory failure Differentials of extrapulmonary causes of respiratory failure: Central nervous system–Respiratory center depression due to causes such as drug overdose, primary alveolar hypoventilation, and myxedema. Peripheral nervous system–Spinal cord diseases, Guillain-Barré syndrome, Amyotrophic lateral sclerosis. Respiratory muscles–Hypophosphatemia, muscle fatigue, myasthenia gravis, and polymyositis. Chest wall diseases–Ankylosing spondylitis, flail chest, thoracoplasty. Pleural diseases–Restrictive pleuritis Upper air way obstruction–Tracheal Stenosis, vocal cord tumor

Compensation

Rules of compensation

The compensatory response depends upon the proper functioning of the organ system involved in the response (lungs or kidneys) and on the severity of acid–base disturbance. For example, the likelihood of complete compensation in chronic respiratory acidosis is <15% when paCO2 exceeds 60 mmHg. Acute compensation occurs within 6–24 h and chronic within 1–4 days. Respiratory compensation occurs faster than metabolic compensation. In clinical practice, it is rare to see complete compensation. The maximum compensatory response in most cases is associated with only 50–75% return of pH to normal. However, in chronic respiratory alkalosis, the pH may actually completely return to normalcy in some cases.

Respiratory acidosis

Acute: [HCO3-] increase by 1 mEq/L for every 10 mmHg increase in paCO2 above 40. Chronic: [HCO3-] increase by 3.5 mEq/L for every 10 mmHg increase in paCO2 above 40.

Respiratory alkalosis

Acute: [HCO3-] decrease by 2 mEq/L for every 10 mmHg decrease in paCO2 below 40. Chronic: [HCO3-] decrease by 5 mEq/L for every 10 mmHg decrease in paCO2 below 40.

Metabolic disorders

In patients with metabolic acidosis, an excess of acid or loss of base is present. This causes the HCO3-:H2CO3ratio and pH to fall while no change occurs in pCO2–uncompensated metabolic acidosis. As a result of compensatory mechanisms, the lungs in the form of CO2 excrete H2CO3 and the kidneys retain HCO3-. pCO2 falls and HCO3-: H2CO3 ratio and pH rise toward normal even though concentrations of HCO3-and H2CO3 are less than normal. This is called compensated metabolic acidosis and the expected paCO2 is calculated as paCO2 = [1.5 × HCO3+ 8] ± 2.

Anion gap

For more than 40 years, the AG theory has been used by clinicians to exploit the concept of electroneutrality and has evolved as a major tool for evaluating the acid–base disorder. Anion gap is the difference between the charges of plasma anions and cations, calculated from the difference between the routinely measured concentration of the serum cations (Na+ and K+) and anions (Cl- and HCO3-). Because electroneutrality must be maintained, the difference reflects the unmeasured ions. Normally, this difference or the gap is filled by the weak acids (A-) principally albumin, and to a lesser extent phosphates, sulfates, and lactates. When the AG is greater than that produced by the albumin and phosphate, other anions (e.g., lactates and ketones) must be present in higher than normal concentration. Anion gap = (Na+ + K+) - [Cl- + HCO3-] Because of its low and narrow extracellular concentration, K+ is often omitted from the calculation The normal value ranges from 12 ± 4 when K+ is considered, and 8 ± 4 when K+ is omitted. Figure 3 shows the alogrithm for the approach to patients with normal AG acidosis.
Figure 3

Approach to a patient with normal anion gap acidosis

Approach to a patient with normal anion gap acidosis The primary problem with AG is its reliance on the use of the normal range produced by the albumin and to a lesser extent phosphate, the level of which may be grossly abnormal in critically ill patients. Because these anions are not strong anions, their charges will be altered by changes in pH.[1011]

Serum protein and phosphate

Normal AG = 2{albumin(gm/L)} + 0.5 {phosphate (mg/dL)} Acid–base status In Acidemic state - Anion gap decreases by 1-3 In Alkalemic state - Anion gap increases by 2-5

Major clinical uses of the anion gap

For signaling, the presence of a metabolic acidosis and confirm other findings. Helping to differentiate between causes of metabolic acidosis: High AG versus normal AG metabolic acidosis. In an inorganic metabolic acidosis (e.g., due to HCl infusion), the infused Cl- replaces HCO3-, and the AG remains normal. In an organic acidosis, the lost bicarbonate is replaced by the acid anion which is not normally measured. This means that the AG is increased. Providing assistance in assessing the biochemical severity of the acidosis and follow the response to treatment. Disorders that are associated with a low or negative serum AG are listed in Table 2.
Table 2

Disorders associated with low serum anion gap

CauseComments
Laboratory errorMost frequent cause of low anion gap
HypoalbuminemiaSecond most common cause of low serum anion gap
Multiple myelomaLevel of anion gap correlates with serum concentration of paraprotein
Halide intoxicationAnion gap depends on serum halide concentration
(bromide, lithium, iodide)(low anion gap with lithium ≥4 mEq/L)
Hypercalcemiamore likely in hypercalcemia associated with 10 hyperparathyroidism
HypermagnesemiaTheoretical cause but not documented in literature
Polymyxin BAnion gap depends on serum level; occurs with preparation with chloride
Underestimation of serum sodiumMost frequent with hypernatremia or hypertriglyceridemia
Overestimation of serum chlorideRare with ion selective electrodes
Overestimation of serum bicarbonateSpurious in serum HCO3 if cells not separated from sera
Disorders associated with low serum anion gap Table 3 elaborates the species of the unaccounted anions along with their sources of origin and diagnostic adjunts in case of high AG metabolic acidosis.
Table 3

Description of the species of unmeasured anions, source of origin, and diagnostic adjuncts in case of high anion gap metabolic acidosis

CauseHigh serum anion gap
Comments
SpeciesOriginDiagnostic adjuncts
Renal failurePhosphates, sulphatesProtein metabolismBUN/creatinine
KetocidosisKetoacidsFatty acid metabolismSerum/urine ketones
 Diabeticβ Hydroxybutyrate
 Alcoholic
 StarvationAcetoacetate
Lactic acidosisLactateLactate levels
Exogenous poisoningSalicylateSalicylateConcomitant
LactateRespiratory and metabolic alkalosis
ketoacids
Description of the species of unmeasured anions, source of origin, and diagnostic adjuncts in case of high anion gap metabolic acidosis In the patients with metabolic alkalosis, there is an excess of base or a loss of acid which causes the HCO3-:H2CO3 ratio and pH to rise, but with no change occurring in pCO2, which is called uncompensated metabolic alkalosis. However, the kidney has a large capacity to excrete excess bicarbonate and so, for sustaining the metabolic alkalosis, the elevated HCO3-concentration must be maintained through an abnormal renal retention of HCO3-. Compensatory respiratory acidosis may be so marked that pCO2 may rise higher than 55 mmHg. Expected paCO2is calculated as paCO2 = [0.7 × HCO3-+ 21] ± 2 or 40 + [0.7 ΔHCO3]. This is called compensated metabolic alkalosis. Most of the patients with metabolic alkalosis can be treated with chloride ions in the form of NaCl (saline responsive) rather than KCl (which is preferable). When NaCl is given, Cl-ions are supplied, and so the blood volume increases and the secretion of aldosterone in excess decreases. Thus, excessive urinary loss of K+and excessive reabsorption of HCO3- stops. When metabolic alkalosis is due to the effects of excessive aldosterone or other mineralocorticoids, the patient does not respond to NaCl (saline resistant) and requires KCl. Based on the urinary chloride, metabolic alkalosis is divided into: Chloride responsive or extracellular volume depletion (urinary chloride < 20) Vomiting Diuretic Post hypercapnic Chronic diarrhea Chloride resistant (urinary chloride > 20) Severe potassium depletion Mineralocorticoid excess–Primary hypealdosteronism, Cushing’s Syndrome, Ectopic ACTH Secondary hypereldosteronism–Renovascular disease, malignant hypertension, CHF, cirrhosis

Aproach to mixed disorder

Mixed metabolic disturbances (e.g., high AG from diabetic ketoacidosis plus normal AG from diarrhea) can be identified using the relationship between AG and HCO3-, which is called the gap–gap ratio. It is the ratio of change in anion gap (ΔAG) to change in HCO3-HCO3-). When hydrogen ions accumulate in blood, the decrease in serum HCO3- is equivalent to the increase in AG and the increase in AG excess/HCO3- deficit ratio is unity, i.e., pure increase in AG metabolic acidosis. When a normal AG acidosis is present, the ratio approaches zero. When a mixed acidosis is present (high AG + normal AG), the gap–gap ratio indicates the relative contribution of each type to the acidosis. If it is <1, then it suggests that there is a normal AG metabolic acidosis associated with it and if >2 it suggests that there is associated metabolic acidosis.

Rules for rapid clinical interpretation of ABG

When required to make a proper approach towards the evaluation of blood gas and acid–base disturbances in the body, the following scheme is suggested: Look at pH - < 7.40 - Acidosis; > 7.40 - Alkalosis If pH indicates acidosis, then look at paCO2and HCO3- If paCO2is ↑, then it is primary respiratory acidosis To determine whether it is acute or chronic ΔH+ / ΔpaCO2 <0.3–chronic >0.8–acute 0.3-0.8–acute on chronic Calculate compensation by the respective methods Acute: [HCO3-] ↑ by 1 mEq/L for every 10 mmHg ↑ in paCO2 above 40. Chronic: [HCO3-] ↑ by 3.5 mEq/L for every 10 mmHg ↑ in paCO2 above 4 If paCO2↓ and HCO3- is also ↓→ primary metabolic acidosis Calculate expected paCO2as follows: paCO2 = [1.5 × HCO3+ 8] ± 2 metabolic acidosis only paCO2 < expected paCO2→ concomitant respiratory alkalosis. paCO2 > expected paCO2→ concomitant respiratory acidosis If HCO3-is ↓, then AG should be examined. If AG is unchanged → then it is hyperchloremic metabolic acidosis. If AG is ↑ → then it is wide AG acidosis. Check gap-gap ratio ΔAG/Δ HCO3- = 1, pure increased AG metabolic acidosis <1 normal anion gap metabolic acidosis >2 associated metabolic acidosis. If pH indicates alkalosis, then look at HCO3- and paCO2. If paCO2is ↓ → then it is primary respiratory alkalosis. Whether it is acute or chronic (with the same formula as above) Calculate compensation by the respective methods: Acute: [HCO3-]↓ by 2 mEq/L for every 10 mmHg ↓ in paCO2below 40. Chronic: [HCO3-] ↓ by 5 mEq/L for every 10mmHg ↓ in paCO2 below 40. If paCO2 ↑ and HCO3- also ↑ → then it is primary metabolic alkalosis. Calculate the expected paCO2 paCO2 = [0.7 × HCO3-+ 21] ± 2 Or 40 + [0.7 ΔHCO3] → metabolic alkalosis only paCO2 < expected paCO2 → concomitant respiratory alkalosis. paCO2 > expected paCO2 → concomitant respiratory acidosis Check urinary chloride if urinary chloride < 20 → chloride responsive or ECV depletion if urinary chloride > 20→ chloride resistant If pH is normal ABG may be normal or mixed disorder paCO2 and ↓HCO3-→ respiratory and metabolic acidosis (b) ↓paCO2 and↑ HCO3-→ respiratory and metabolic alkalosis. Calculate % difference (ΔHCO3-/HCO3-and ΔpaCO2/paCO2) to see which is dominant disorder.
  6 in total

1.  Letter: Arterial blood gas levels after oxygen therapy.

Authors:  C R Woolf
Journal:  Chest       Date:  1976-06       Impact factor: 9.410

2.  Too much heparin: possible source of error in blood gas analysis.

Authors:  A S Hutchison; S H Ralston; F J Dryburgh; M Small; I Fogelman
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-15

3.  Simple and mixed acid-base disorders: a practical approach.

Authors:  R G Narins; M Emmett
Journal:  Medicine (Baltimore)       Date:  1980-05       Impact factor: 1.889

4.  The influence of anticoagulation on acid-base status and blood-gas analysis.

Authors:  U Börner; H Müller; R Höge; G Hempelmann
Journal:  Acta Anaesthesiol Scand       Date:  1984-06       Impact factor: 2.105

5.  Dry electrolyte-balanced heparinized syringes evaluated for determining ionized calcium and other electrolytes in whole blood.

Authors:  J Toffaletti; P Ernst; P Hunt; B Abrams
Journal:  Clin Chem       Date:  1991-10       Impact factor: 8.327

6.  Anion gap, anion gap corrected for albumin, base deficit and unmeasured anions in critically ill patients: implications on the assessment of metabolic acidosis and the diagnosis of hyperlactatemia.

Authors:  Lakhmir S Chawla; Shirley Shih; Danielle Davison; Christopher Junker; Michael G Seneff
Journal:  BMC Emerg Med       Date:  2008-12-16
  6 in total
  19 in total

1.  Analysis of Arterial Blood Gas Report in Chronic Kidney Diseases - Comparison between Bedside and Multistep Systematic Method.

Authors:  Ishita Ghatak; Vaishali Dhat; Mona A Tilak; Indranath Roy
Journal:  J Clin Diagn Res       Date:  2016-08-01

2.  Dangers of very low blood pH.

Authors:  Viktor Rosival
Journal:  Indian J Crit Care Med       Date:  2011-07

Review 3.  Acid-base disorders in patients with chronic obstructive pulmonary disease: a pathophysiological review.

Authors:  Cosimo Marcello Bruno; Maria Valenti
Journal:  J Biomed Biotechnol       Date:  2012-02-01

4.  Demarcation of Sepsis-Induced Peripheral and Central Acidosis with pH (Low) Insertion Cycle Peptide.

Authors:  Kelly E Henry; Aisling M Chaney; Veronica L Nagle; Haley C Cropper; Saghar Mozaffari; Gregory Slaybaugh; Keykavous Parang; Oleg A Andreev; Yana K Reshetnyak; Michelle L James; Jason S Lewis
Journal:  J Nucl Med       Date:  2020-01-31       Impact factor: 11.082

5.  Cramps and tingling: A diagnostic conundrum.

Authors:  Mrunalini Parasa; Shaik Mastan Saheb; Nagendra Nath Vemuri
Journal:  Anesth Essays Res       Date:  2014 May-Aug

6.  Predict respiratory distress syndrome by umbilical cord blood gas analysis in newborns with reassuring Apgar score.

Authors:  Giuseppe De Bernardo; Rita De Santis; Maurizio Giordano; Desiree Sordino; Giuseppe Buonocore; Serafina Perrone
Journal:  Ital J Pediatr       Date:  2020-02-12       Impact factor: 2.638

7.  Developing an animal model to detect drug-drug interactions impacting drug-induced respiratory depression.

Authors:  Lin Xu; Ashok Chockalingam; Sharron Stewart; Katherine Shea; Murali K Matta; Suresh Narayanasamy; Nageswara R Pilli; Donna A Volpe; James Weaver; Hao Zhu; Michael C Davis; Rodney Rouse
Journal:  Toxicol Rep       Date:  2020-01-25

Review 8.  Blood gas analysis for bedside diagnosis.

Authors:  Virendra Singh; Shruti Khatana; Pranav Gupta
Journal:  Natl J Maxillofac Surg       Date:  2013-07

9.  Ganoderma lucidum aqueous extract prevents hypobaric hypoxia induced memory deficit by modulating neurotransmission, neuroplasticity and maintaining redox homeostasis.

Authors:  Purva Sharma; Rajkumar Tulsawani
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

10.  Effects of mineral waters on acid-base status in healthy adults: results of a randomized trial.

Authors:  Paulina Wasserfurth; Inga Schneider; Alexander Ströhle; Josefine Nebl; Norman Bitterlich; Andreas Hahn
Journal:  Food Nutr Res       Date:  2019-12-03       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.